Antipodes Partners LTD Merck & Co., Inc. Transaction History

Antipodes Partners LTD

  • $3 Billion
  • Q2 2025

A detailed history of Antipodes Partners LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 1,814,260 shares of MRK stock, worth $162 Million. This represents 4.78% of its overall portfolio holdings.

Number of Shares
1,814,260
Previous 1,967,970 7.81%
Holding current value
$162 Million
Previous $177 Million 18.7%
% of portfolio
4.78%
Previous 5.59%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025
SELL
$73.47 - $87.12 $11.3 Million - $13.4 Million
-153,710 Reduced 7.81%
1,814,260 $144 Million
Q1 2025

May 06, 2025
BUY
$83.01 - $101.02 $9.91 Million - $12.1 Million
119,339 Added 6.46%
1,967,970 $177 Million
Q4 2024

Feb 10, 2025
BUY
$96.31 - $114.76 $26.3 Million - $31.3 Million
272,815 Added 17.31%
1,848,631 $184 Million
Q3 2024

Nov 13, 2024
SELL
$111.15 - $128.97 $11.1 Million - $12.9 Million
-99,830 Reduced 5.96%
1,575,816 $179 Million
Q2 2024

Aug 05, 2024
SELL
$123.8 - $132.96 $26.5 Million - $28.4 Million
-213,659 Reduced 11.31%
1,675,646 $207 Million
Q1 2024

May 06, 2024
SELL
$113.24 - $131.95 $32.3 Million - $37.7 Million
-285,599 Reduced 13.13%
1,889,305 $249 Million
Q4 2023

Jan 24, 2024
SELL
$100.18 - $109.02 $9.53 Million - $10.4 Million
-95,095 Reduced 4.19%
2,174,904 $237 Million
Q3 2023

Nov 09, 2023
BUY
$102.95 - $114.33 $53.6 Million - $59.5 Million
520,841 Added 29.78%
2,269,999 $237 Million
Q2 2023

Jul 25, 2023
SELL
$108.61 - $118.38 $11.7 Million - $12.7 Million
-107,402 Reduced 5.79%
1,749,158 $202 Million
Q1 2023

May 11, 2023
BUY
$102.94 - $114.86 $115,395 - $128,758
1,121 Added 0.06%
1,856,560 $198 Million
Q4 2022

Feb 08, 2023
SELL
$87.44 - $112.11 $35.8 Million - $45.9 Million
-409,457 Reduced 18.08%
1,855,439 $206 Million
Q3 2022

Nov 10, 2022
BUY
$84.53 - $94.96 $26.7 Million - $30 Million
316,431 Added 16.24%
2,264,896 $195 Million
Q2 2022

Aug 12, 2022
SELL
$83.49 - $94.64 $20 Million - $22.6 Million
-239,177 Reduced 10.93%
1,948,465 $178 Million
Q1 2022

Apr 21, 2022
BUY
$73.51 - $82.4 $16.3 Million - $18.3 Million
222,174 Added 11.3%
2,187,642 $179 Million
Q4 2021

Apr 21, 2022
SELL
$72.28 - $90.54 $384,601 - $481,763
-5,321 Reduced 0.27%
1,965,468 $151 Million
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $4.94 Million - $6.18 Million
68,277 Added 3.59%
1,970,789 $161 Million
Q3 2021

Nov 15, 2021
SELL
$71.68 - $78.83 $11.1 Million - $12.2 Million
-154,947 Reduced 7.53%
1,902,512 $143 Million
Q2 2021

Aug 17, 2021
BUY
$70.31 - $77.77 $1.73 Million - $1.92 Million
24,642 Added 1.21%
2,057,459 $160 Million
Q1 2021

May 13, 2021
BUY
$68.86 - $81.11 $7.12 Million - $8.39 Million
103,441 Added 5.36%
2,032,817 $157 Million
Q4 2020

Feb 16, 2021
BUY
$71.77 - $79.65 $13.9 Million - $15.4 Million
193,495 Added 11.15%
1,929,376 $158 Million
Q3 2020

Nov 10, 2020
SELL
$73.18 - $82.95 $11.3 Million - $12.8 Million
-154,012 Reduced 8.15%
1,735,881 $144 Million
Q2 2020

Jul 30, 2020
BUY
$70.42 - $80.13 $2.63 Million - $2.99 Million
37,302 Added 2.01%
1,889,893 $146 Million
Q1 2020

May 07, 2020
BUY
$63.36 - $87.82 $117 Million - $163 Million
1,852,591 New
1,852,591 $143 Million
Q4 2019

Feb 05, 2020
SELL
$77.58 - $87.54 $137 Million - $155 Million
-1,768,365 Closed
0 $0
Q3 2019

Nov 06, 2019
BUY
$76.08 - $82.93 $23.1 Million - $25.2 Million
303,391 Added 20.71%
1,768,365 $149 Million
Q2 2019

Aug 14, 2019
BUY
$69.84 - $81.59 $102 Million - $120 Million
1,464,974 New
1,464,974 $0

Others Institutions Holding MRK

# of Institutions
3,842
Shares Held
1.96B
Call Options Held
29.2M
Put Options Held
30M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $226B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Antipodes Partners LTD Portfolio

Follow Antipodes Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email